Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) Accumulated Depreciation & Amortization (2016 - 2025)

Bio-Techne has reported Accumulated Depreciation & Amortization over the past 16 years, most recently at $293.1 million for Q4 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at $293.1 million for Q4 2025, up 8.43% from a year ago — trailing twelve months through Dec 2025 was $293.1 million (up 8.43% YoY), and the annual figure for FY2025 was $286.1 million, up 11.53%.
  • Accumulated Depreciation & Amortization for Q4 2025 was $293.1 million at Bio-Techne, up from $289.0 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for TECH hit a ceiling of $293.1 million in Q4 2025 and a floor of $186.9 million in Q1 2021.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $237.3 million (2023), compared with a mean of $238.6 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: rose 12.36% in 2021 and later increased 8.43% in 2025.
  • Bio-Techne's Accumulated Depreciation & Amortization stood at $201.1 million in 2021, then grew by 11.07% to $223.3 million in 2022, then grew by 9.79% to $245.2 million in 2023, then grew by 10.24% to $270.3 million in 2024, then rose by 8.43% to $293.1 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $293.1 million (Q4 2025), $289.0 million (Q3 2025), and $286.1 million (Q2 2025) per Business Quant data.